Papadopoulou Katharina, Karsai Syrus, Böer-Auer Almut
Dermatologikum Hamburg, Stephansplatz 5, Hamburg, Germany.
Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
J Dtsch Dermatol Ges. 2022 Nov;20(11):1423-1429. doi: 10.1111/ddg.14897. Epub 2022 Oct 31.
Dowling-Degos disease is a rare benign genodermatosis. It is characterized by lentiginous hyperpigmentation and reddish-brown papules and plaques. The flexor sides and intertrigines are often affected, but the clinical appearance may vary. Mutations in different genes are responsible for the clinical manifestation. While mutations in the keratin 5 (KRT5) gene favor a reticular distribution pattern, mutations in the POGLUT1 gene lead to a disseminated, papular clinical picture. Acantholytic variants of Dowling-Degos disease have historically been referred to as Galli-Galli disease, but our case study shows that the histopathological changes can vary even within a single patient. To date, no standardized therapy concept exists. The main focus is on keratolytic measures, with varying response. New therapeutic approaches using laser technology appear to be a promising treatment option.
道林-迪戈斯病是一种罕见的良性遗传性皮肤病。其特征为雀斑样色素沉着以及红棕色丘疹和斑块。屈侧和摩擦部位常受累,但临床表现可能有所不同。不同基因的突变导致了临床表现。虽然角蛋白5(KRT5)基因突变倾向于网状分布模式,但POGLUT1基因突变会导致播散性丘疹临床表现。道林-迪戈斯病的棘层松解变异型在历史上被称为加里-加里病,但我们的病例研究表明,即使在单个患者体内,组织病理学变化也可能不同。迄今为止,尚无标准化的治疗方案。主要侧重于角质松解措施,反应各异。使用激光技术的新治疗方法似乎是一种有前景的治疗选择。